Y51* (p.Tyr51Ter) variant of TAFAZZIN (Q16635)
Y51* (p.Tyr51Ter) in TAFAZZIN (Q16635) is a protein-truncating change. Clinical records from EBI and UniProt describe it as pathogenic. The record also includes published literature and structural context.
Y51* (p.Tyr51Ter) variant details
- p.Tyr51Ter
- rs104894941
- ClinGen CA255717
- ClinVar RCV000011850
- ClinVar RCV001091834
- Pathogenic
- Stop Gained
- EBI: Pathogenic
- UniProt: Pathogenic
- Structural context available
- Cited in: X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. (PMID 15098233)
- Cited in: Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome)… (PMID 1998334)